Approval · Notice of Compliance 16495 · 2015
SERC: Notice of Compliance 16495
Issued January 7, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16495
- Date
- January 7, 2015
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Anti-vertigo agent
Products in this notice
Medicinal ingredients
- BETAHISTINE HYDROCHLORIDE 16 MG per TAB
- BETAHISTINE HYDROCHLORIDE 24 MG per TAB